Back

Mechanisms underlying alternans and oscillation during sustain VT: insights from high density mapping of the isthmus

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Mapping protocols in ablation of ventricular arrhythmias Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Shoma Kitano

Toho University Ohashi Medical Center, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Systematic use of automatic high-density late annotation mapping for ventricular tachycardia ablation procedures - The SLAM-VT study
Professor C. Heeger (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Diagnostic accuracy of a novel functional extra-stimulus mapping metric: Ventricular Electrogram Duration Mapping of Extra-stimulus (VEDUM-X) in defining the ventricular tachycardia substrate
Mr J. Mayer (Stoke-on-Trent, GB)
Abstract Slides Video
Presentation thumbnail
Unveiling deceleration zones through the s3 protocol: a functional substrate mapping for ventricular tachycardia ablation
Doctor N. Pierucci (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
High output pace mapping on the right coronary cusp to avoid atrioventricular conduction injury in a patient with an RCC-ventricular arrhythmia
Doctor H. Hachiya (Tsuchiura, JP)
Abstract Slides Video
Presentation thumbnail
Effects of pacing sites on substrate mapping using decrement-evoked potential mapping for scar-related ventricular tachycardia
Associate Professor J. Uhm (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Mapping protocols in ablation of ventricular arrhythmias

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources